Experiences with interferon-beta-1b treatment in MS after three year follow-up

Swiss Med Wkly. 2002 May 4;132(17-18):237. doi: 10.4414/smw.2002.09810.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adjuvants, Immunologic / therapeutic use*
  • Clinical Trials, Phase IV as Topic*
  • Follow-Up Studies
  • Humans
  • Interferon beta-1a
  • Interferon beta-1b
  • Interferon-beta / therapeutic use*
  • Multiple Sclerosis / drug therapy*
  • Time Factors
  • Treatment Outcome

Substances

  • Adjuvants, Immunologic
  • Interferon beta-1b
  • Interferon-beta
  • Interferon beta-1a